Global market to hit US$740bn in 2026, longevity needs lifts? ‘little brain’s’ big role, ageing ethics questioned…and more IRISH insight and analysis company Research and Markets...
Despite having its application for a new, daily Alzheimer’s pill rejected by Europe’s regulators the CEO of US drug company Anavex Life Sciences is appealing this...
NIH funding of US$80m will support further research into exceptional longevity, continuing a long-running study of families whose members live far longer than statistical models predict....
Eanm has launched a new award to accelerate alpha radioligand therapy research in prostate cancer, with winners to be announced at the EANM’26 Congress. Applications are...
Researchers are studying recovery after bowel cancer treatment in older people, as the REBOUND study looks at ageing changes linked to surgery and care. The study,...
Long-term air pollution exposure may raise Alzheimer’s risk mainly through direct effects on the brain, a study of US Medicare records suggests. The research followed more...
Processing-speed brain training with booster sessions was linked to a lower dementia diagnosis risk over 20 years, according to a long follow-up study. The findings come...
